UBS Group’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-600
Closed -$6K 8459
2015
Q1
$6K Sell
600
-900
-60% -$9.91K ﹤0.01% 7988
2014
Q4
$17K Buy
+1,500
New +$15.5K ﹤0.01% 7858

Other funds holding AORT

UBS Group's AORT Position: Q1 2026 in Review

UBS Group reduced its Artivion (AORT) stake by 8.1% in Q1 2026, selling an estimated $898K and leaving 256,922 shares worth $9.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3428.

UBS Group first reported a position in AORT in Q4 2014 and has held it in 46 quarters since. The position peaked at $12.8M in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • UBS Group held 256,922 shares of Artivion worth $9.41M as of Q1 2026.
  • UBS Group sold 22,753 Artivion shares in Q1 2026, an estimated $898K.
  • Artivion made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3428 holding.
  • UBS Group first reported a position in Artivion in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Artivion position peaked at $12.8M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.